title: [Diagnosis and treatment of depression in the advanced stage of cancer].
abstract: The diagnosis of depression in patients with advanced cancer is a particularly complex task. The lack of diagnostic tools specifically developed for this patient population, the difficulty of interpreting neurovegetative symptoms of depression--which can result from the neoplastic disease--and the "normal and understandable" nature of many symptoms or signs of psychological distress are among the main obstacles to a clear-cut diagnosis of depression. Things go even more complex when it comes about to discuss whether one should treat patients displaying psychological distress that does not meet established criteria for the diagnosis of a depressive illness. When the indication to treat is finally acknowledged, the choice of the optimal antidepressant will depend upon a series of parameters including survival expectancy, tolerance profile and drug interactions. Though we currently lack prospective data about the efficacy and safety of antidepressants in depressed patients with advanced cancer, extrapolation of data available from other patient populations with severe medical conditions and clinical experience allow to draw guidelines aimed at helping healthcare professionals faced with those problems to improve the quality of life of their patients. These elements are presented and discussed in this paper in the light of the recent developments resulting from the growing interest of the medical community to the care to patients with terminal illness.
authors.affiliation: Service de Médecine Interne, Clinique des Soins Supportifs et Palliatifs, Institut Jules Bordet, U.L.B.
authors.forename: A
authors.initials: A
authors.lastname: Ronson
mesh_terms: D000928:Antidepressive Agents / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use; D001601:Bereavement; D003866:Depressive Disorder / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000523:psychology / Q000628:therapy*; D004347:Drug Interactions; D006801:Humans; D009369:Neoplasms / Q000150:complications* / Q000523:psychology; D018579:Patient Selection; D015995:Prevalence; D011569:Psychiatric Status Rating Scales; D011788:Quality of Life; D013727:Terminal Care / Q000379:methods / Q000523:psychology
chemical_list: D000928:Antidepressive Agents